Clinical trial
Does GM-CSF Restore Effective Neutrophil Function in Critically Ill Patients?
NCT01653665 is registered in ClinicalTrials.gov with Newcastle-upon-Tyne Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does GM-CSF Restore Effective Neutrophil Function in Critically Ill Patients?
- Lead sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- February 28, 2015
- Enrollment
- 64 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, immuno-suppression, sepsis